NCT02459158 - A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 22, 2017

Study Completion Date

March 22, 2017

Conditions

Pneumonia, Bacterial

Interventions

DRUG

ME1100 inhalation solution

Low dose of ME1100 inhalation solution twice daily for up to 14 days to be administered via eFlow nebulizer system

DRUG

ME1100 inhalation solution

High dose of ME1100 inhalation solution twice daily for up to 14 days to be administered via eFlow nebulizer system

Trial Locations (14)

Martinez

Sacramento

San Diego

Aurora

Jacksonville

Hazard

Worcester

Kalamazoo

Buffalo

Greensboro

Cincinnati

Lima

Toledo

Houston